Ayumi Murakami

Summary

Affiliation: Yokohama City University
Country: Japan

Publications

  1. ncbi Sebaceous carcinoma of the breast
    Ayumi Murakami
    Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan
    Pathol Int 59:188-92. 2009
  2. ncbi The topoisomerase II alpha gene status in primary breast cancer is a predictive marker of the response to anthracycline-based neoadjuvant chemotherapy
    Kae Kawachi
    Division of Anatomic and Surgical Pathology, Yokohama City University Medical Center, Minami Ku, Yokohama, Japan
    Pathol Res Pract 206:156-62. 2010
  3. ncbi Unilateral glomerulocystic kidney disease associated with tuberous sclerosis complex in a neonate
    Ayumi Murakami
    Division of Pathology, Kanagawa Children s Medical Center Department of Pathology, Yokohama City University Graduate School of Medicine, Kanazawa Ku, Yokohama, Japan
    Pathol Int 62:209-15. 2012
  4. ncbi Hepatocellular carcinoma occurring in a young Crohn's disease patient
    Ayumi Murakami
    Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan
    Pathol Int 59:492-6. 2009
  5. ncbi A novel method for isolating podocytes using magnetic activated cell sorting
    Ayumi Murakami
    Department of Pathology, Yokohama City University School of Medicine 3 9 Fukuura, Kanazawa Ku, Yokohama 236 0004, Japan
    Nephrol Dial Transplant 25:3884-90. 2010

Collaborators

Detail Information

Publications5

  1. ncbi Sebaceous carcinoma of the breast
    Ayumi Murakami
    Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan
    Pathol Int 59:188-92. 2009
    ..This is the first case of an androgen receptor-positive mammary SC to be reported, and therefore contributes to the understanding of the clinicopathological features of SC of the breast...
  2. ncbi The topoisomerase II alpha gene status in primary breast cancer is a predictive marker of the response to anthracycline-based neoadjuvant chemotherapy
    Kae Kawachi
    Division of Anatomic and Surgical Pathology, Yokohama City University Medical Center, Minami Ku, Yokohama, Japan
    Pathol Res Pract 206:156-62. 2010
    ..TOP2A overexpression was not significantly associated with response (p=0.580). Our results thus suggest that the TOP2A/CEP17 ratio may be a useful predictor of the effects of anthracycline-based neoadjuvant chemotherapy in breast cancer...
  3. ncbi Unilateral glomerulocystic kidney disease associated with tuberous sclerosis complex in a neonate
    Ayumi Murakami
    Division of Pathology, Kanagawa Children s Medical Center Department of Pathology, Yokohama City University Graduate School of Medicine, Kanazawa Ku, Yokohama, Japan
    Pathol Int 62:209-15. 2012
    ..These results imply that one more molecular event might be necessary for cyst formation in GCKD associated with TSC, in addition to the activation of mTOR signaling...
  4. ncbi Hepatocellular carcinoma occurring in a young Crohn's disease patient
    Ayumi Murakami
    Department of Pathology, Yokohama City University Medical Center, Yokohama, Japan
    Pathol Int 59:492-6. 2009
    ..Accumulation of cases is necessary to evaluate the relationship between CD and HCC precisely...
  5. ncbi A novel method for isolating podocytes using magnetic activated cell sorting
    Ayumi Murakami
    Department of Pathology, Yokohama City University School of Medicine 3 9 Fukuura, Kanazawa Ku, Yokohama 236 0004, Japan
    Nephrol Dial Transplant 25:3884-90. 2010
    ..In this study, we have developed a novel method of rapid isolation of podocytes from mice using magnetic activated cell sorting with an anti-nephrin antibody...